Real-World Effectiveness of Menopausal Hormone Therapy in Preventing Relapse in Women With Schizophrenia or Schizoaffective Disorder
The findings underscore the potential value of MHT in preventing psychosis relapse among women with SSD of menopausal age. These findings translate clinical evidence on the neuroprotective effects of estrogens to real-world settings, encompassing a group of women for whom current antipsychotic treatment options may be insufficient.
Authors
- Shiral S. Gangadin (ORCID: https://orcid.org/0000-0002-0084-8226)
- Heidi T. Taipale (ORCID: https://orcid.org/0000-0002-3281-934X)
- Jari Tiihonen (ORCID: https://orcid.org/0000-0002-0400-6798)
- Antti Tanskanen (ORCID: https://orcid.org/0000-0001-9065-0960)
- I. Sommer (ORCID: https://orcid.org/0000-0002-2682-5313)
- Bodyl A. Brand
Institutions
- University College of Opera in Stockholm (SE)
Publication Details
- Journal
- American Journal of Psychiatry
- Published
- 2024-09-12
- DOI
- https://doi.org/10.1176/appi.ajp.20230850
- Citations
- 14
- Primary Topic
- Menopause: Health Impacts and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 5.01